Share on StockTwits

Omnicell (NASDAQ:OMCL) VP Nhat H. Ngo sold 1,964 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $26.38, for a total transaction of $51,810.32. Following the completion of the sale, the vice president now directly owns 50,932 shares of the company’s stock, valued at approximately $1,343,586. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Omnicell (NASDAQ:OMCL) traded up 1.14% during mid-day trading on Thursday, hitting $26.65. The stock had a trading volume of 459,296 shares. Omnicell has a 1-year low of $18.74 and a 1-year high of $30.33. The stock has a 50-day moving average of $26.39 and a 200-day moving average of $26.59. The company has a market cap of $975.5 million and a P/E ratio of 35.70.

Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. The company had revenue of $101.80 million for the quarter, compared to the consensus estimate of $97.49 million. During the same quarter in the previous year, the company posted $0.21 earnings per share. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Analysts expect that Omnicell will post $1.23 EPS for the current fiscal year.

A number of research firms have recently commented on OMCL. Analysts at Topeka Capital Markets initiated coverage on shares of Omnicell in a research note on Thursday. They set a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Omnicell in a research note on Thursday, May 29th. They now have a $28.00 price target on the stock. Finally, analysts at Stephens initiated coverage on shares of Omnicell in a research note on Tuesday, May 20th. They set an “overweight” rating on the stock. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $30.83.

Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.